|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2009-5-22
|
|
pubmed:abstractText |
Oxaliplatin is the third-generation platinum complex to be active in advanced colorectal cancer. In Japan, it was approved in April 2005. FOLFOX regimen(a combination of leucovorin and fluorouracil with oxaliplatin) has been one of the standard chemotherapy regimens for metastatic colorectal cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0385-0684
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
36
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
797-801
|
|
pubmed:meshHeading |
pubmed-meshheading:19461180-Adult,
pubmed-meshheading:19461180-Aged,
pubmed-meshheading:19461180-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19461180-Colorectal Neoplasms,
pubmed-meshheading:19461180-Disease Progression,
pubmed-meshheading:19461180-Dose-Response Relationship, Drug,
pubmed-meshheading:19461180-Female,
pubmed-meshheading:19461180-Fluorouracil,
pubmed-meshheading:19461180-Humans,
pubmed-meshheading:19461180-Leucovorin,
pubmed-meshheading:19461180-Male,
pubmed-meshheading:19461180-Middle Aged,
pubmed-meshheading:19461180-Neoplasm Metastasis,
pubmed-meshheading:19461180-Organoplatinum Compounds,
pubmed-meshheading:19461180-Survival Rate,
pubmed-meshheading:19461180-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
|
|
pubmed:affiliation |
Dept. of Surgery, Tosei General Hospital, Aichi, Japan.
|
|
pubmed:publicationType |
Journal Article
|
